Week 289 Review - Absolutely brilliant week everywhere except Optibiotix

Sometimes I could howl in frustration! This should have been a stunning week, but a badly worded and disappointing trading update from OPTI:Optibiotix spoilt everything. I was relieved the drop was only 4p, but that's worth £5,200. It goes to show what a fantastic week it was elsewhere that I ended up £7 better off as all my other shares rallied to counter the drop. That leaves the deficit between cost and value at £6,926 and overall portfolio value up to £123,472, which is around £500 more thanks to banking some profit and re-investing.

OPTI:Optibiotix was the only share that dropped by 5% or more, falling 7%. It could have been a whole lot worse if there hadn't been a rally in the lead up to the trading update. How can a company so poorly manage its comms that a 100%+ increase in revenues is regarded as really bad news. The problem was, shareholders were expecting a 200% increase in revenue from all the comments made over the last 12 months. A lot of long term holders have either baled out completely or sold a significant proportion of their shares. I haven't sold a single share because I still believe this is a long term winner. There is a lot of news in the pipeline so hopefully this is a temporary setback.

DDDD:4D Pharma climbed 15% this week, which is great as a lot of that came after I bought some more. I decided to top slice a few JLP:Jubilee Metals after the recent run and sold 10,000 of my 100,000 for 14.605p after buying them for 4.3p. That gave me £1,018.15 (230.1%) profit and liberated £1,448.55. I used that to buy 1,133 DDDD shares at 128.625p costing £1,469.27. Happy to say they climbed to 147p, and when added to my existing 1,637 shares are in potential profit of £379 (10%). My SIPP holding is up 15% and making £479 potential profit, and my trading holding is up 8% making £39 potential profit. At least one of my bacteria company's share price knows how to behave.

CAML:Central Asia Metals zoomed up 16% on the back of base metal price rises and is now 44% up and making £4,290 potential profit. I'm expecting these to get to 340p in short order now they have momentum.

FXPO:Ferrexpo also took advantage of the increasing metals prices to climb 17% and go a spectacular 93% up making £947 potential profit as well as the £101 dividend. I've made a decision about my 12 month review of the magic formula shares. I'm going to sell enough to liberate £1,000 so I can buy a magic formula share higher up the ranking list, but keep the rest as "free" shares for the dividend. I'll only sell the rest if I decide I don't like them any more.

TRX:Tissue Regenix climbed 18% this week, although it's a slightly artificial rise as I bought some more. If Neil Woodford sets up his new fund, then there's no doubt in my mind he will come back to TRX, especially at these crazy low prices. I sold 300 of my CAML:Central Asia Metals shares for 254.21p making £188.79 (35.7%) profit and liberating £750.69. That was enough to buy 87,047 shares in TRX at 0.8566p costing £757.59. Unfortunately they dropped afterwards, but by reducing my weighted average to 1.6p and thanks to a rise early in the week, I ended up 18% higher. Given my first three purchases were 19.4p, 18.2p and 18.4p, it's great that buying a large number at 0.54p and 0.85p has lowered the average so much. The way things are going, I think they could get back to 18p.

Share of the Week is easy, as JLP:Jubilee Metals went utterly berserk and climbed 74%. There seems no stopping it at the moment. My holding is now up by 268% and despite taking £1,000 profit my remaining shares are making £10,412 potential profit. I'm a bit sad I no longer have 100,000, but there were two very important advantages of sacrificing 10,000. One was the DDDD:4D Pharma purchase just in time for them to hopefully significantly re-rate, and the other was to make enough profit to be able to write off one of my most toxic shares BLCC:Block Commodities. I was able to subsume the £707.98 loss without impacting my overall performance and I never have to report on the horrid thing again!

So close to the red line!

Just about staying above the trend line 

Here's the ISA and shares portfolio after week 29 of year 6

			Weekly Change
Cash	£70.69		-£20.72
Portfolio cost	£63,391.43		+£330.89
Portfolio sell value (bid price-commission)	£59,653.12	(-5.9%)	+£254.94
Potential profits	£10,791.92		+£2,419.87
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£1,015.43		+£310.17
Yr 6 projected avg monthly profit	£147.81	(4.2%)	+£42.72
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,442.04		+£310.17
Average monthly cash profit	£337.76	(9.7%)	+£3.49
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	54%		+1%

Only £310 increase in profits after writing off BLCC:Block Commodities £707 loss, as lets face it, they are never coming back. I was duped into their story when they were AFPO:African Potash, until it became clear the whole thing was an utter disaster, meandering from potash to blockchain to marihuana with never the remotest hope of delivering returns to shareholders. It feels great to have got rid of them, despite the fact they are still lurking worthlessly in my account.

With 6 months to go, year 6 is looking a bit poor, but I can get away with this sort of performance as my long term is at 9.7%. Ideally I need another £5k profits in order to get the annual performance to 10%. I'm hoping that will come when I sell my small OPTI:Optibiotix holding in the share account and use it to double the size of my trading account. I just need OPTI to get to 84p which it's trying its best to avoid doing.

Calm before the storm, but will it be nice or nasty?

Above the trend line is satisfactory

The SIPP looks like this after week 273 overall and week 13 of year 6.

			Weekly Change
Cash	£227.20		-£7.26
Portfolio cost	£64,095.12		+£207.65
Portfolio sell value (bid price - commission)	£61,291.71	(-4.4%)	-£362.25
Potential profits	£6,952.99		+£1,993.21
Yr 6 Dividends	£419.17		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£2,564.14		+£188.79
Yr 6 projected avg monthly profit	£977.66	(29.3%)	-£13.42
Total Dividends	£2,486.25		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£18,023.58		+£188.79
Average monthly cash profit	£314.90	(9.4%)	+£1.84
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+0%

The big rise in profits wasn't quite enough to make up for the OPTI:Optibiotix fall, so value dropped a little and long term average was maintained rather then improving very much.

All the charts are looking the same - I think I need to stop buying the same shares in each account!

It's not often the SIPP is performing worse than the ISA, but it's a lot closer to going below the trend line.

The trading account looks like this after week 239 overall and week 31 of year 5

			Weekly Change
Cash	£249.58		+£0
Portfolio cost	£2,364.43		+£0
Portfolio sell value (bid price - commission)	£1,980.08	(-16.3%)	+£114.49
Potential profits	£68.52		+£68.52
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£631.65		+£0
Yr 5 projected avg monthly profit	£90.00	(45.7%)	-£3.20
Dividends	£60.10		+£0
Profit from sales	£918.02		+£0
Average monthly cash profit	£17.73	(9.0%)	-£0.08
(Sold stocks profit + Dividends - Fees  / Months)

Great rise and both CAML:Central Asia Metals and DDDD:4D Pharma have gone into profit. I'll be watching those closely next week with a view to selling. I so badly want to get the £2,500 from selling the OPTI:Optibiotix shares in here as I reckon if I had 10 shares to pick from I've be able to sell at least one a week.

Back towards the recent highs.

Back above the trend line.

I'm trying to decide how I feel about top slicing some of my favourite shares this week. I do feel bad about having less of them than I did before, but when a great opportunity comes along you need to have cash, and I don't have any cash reserves so selling something is the only option. I think it's also good for the morale to bank a little profit now and again, as long as it doesn't impact the long term value of the holding too much.

I was really in two minds about selling 10% of my JLP:Jubilee Metals holding, especially as I'd already sold 42k at the crazy low price of 6.4p for just £835 profit when I could have made £4,293 if I'd held a few more weeks. I wanted more DDDD:4D Pharma before their Nasdaq launch but I wasn't convinced it was a good idea. It was definitely the chance to write off BLCC:Block Commodities that swung it for me, so I think if you have a good enough reason it's ok to sacrifice long term gains. I may not think so when they get to 40p and I look at the £2,500 extra I would have got, but by then DDDD might be £5 a share.

It's almost a year since the big Covid crash, when I really began to think my portfolio was utterly doomed. Those days when it was worth much less than I'd put in were absolutely horrible, when I think about the sacrifices I made to pay off the loans I used to kick start the portfolio. I still have knackered soffits and a hole on my bay window roof because I'm paying back the loans on buying shares and going to Ecuador, although in fairness a lot of that was down to Ecuador! At least now the portfolio is almost back in the black and justifying investing here instead of the building society.

Week 288 Review - A quiet week but massively increased 4D Pharma holding

Aside from taking some small profits and buying a load of DDDD:4D Pharma shares, not a lot happened, but a 2p drop in OPTI:Optibiotix had the usual effect of spoiling everything else. The deficit between cost and value widened by £2,542 to £6,933 and total portfolio value decreased to £122,954

Worst performer was magic formula share PAY:Paypoint which fell 7% and is now only 3% in profit. I don't know why there has been a drop, as they announced the acquisition of RSM2000, which moves them into the card payment arena. I would have expected a tick upwards rather then a big drop. I still see this as adding value and my review date for these isn't until the end of July, so they have plenty of time to come good.

DDDD:4D Pharma fell 5% in my ISA mainly due to spread and commission after I bought a load. In the ISA I sold my IQE:IQE shares for £113.45 (4.9%) profit. Not as much as I wanted, but I thought the timing was right for buying DDDD:4D Pharma. I bought 1,637 shares at 134.3475p costing £2,211.22. My timing wasn't actually right as they dropped to 129.5p bid price. In my SIPP I sold ITX:Itaconix because I wasn't absolutely convinced they could keep their recent gains. I made £202.46 (19.6%) profit and bought 954 DDDD shares at 134.9182p costing £1,299.07. That takes my total holding to 4,221 shares costing £5,517 not including my trading account shares. These are now banked for the long term and will be held as tightly as my OPTI:Optibiotix shares, and added to if the opportunity arises.

HUM:Hummingbird Resources has been a complete disaster and dropped another 5% this week. Why I continue to buy these tin pot little companies I really do not know. I'm now stuck with them until there's a major rally in the gold price.

Not much good news this week, but POLR:Polar Capital Holdings climbed another 6% to go 30% up and making £303 potential profit with another £66 in dividends received so far. I'm very happy with this one.

Share of the Week goes to FXPO:Ferrexpo which is on a great run and climbed another 13% this week to go 76% up, making £768 potential profit and having paid out £101 dividends. This is a shining example for the benefits of the magic formula system for finding good quality cheap chares. Just one more month and I get to transfer another £2,000 from my work pension and re-calculate my ranking list to find the next 2 companies to add.

I was rather hoping we'd bounce back above the red line but it wasn't to be.

Still above the trend line which is nice. 

Here's the ISA and shares portfolio after week 28 of year 6

			Weekly Change
Cash	£91.41		+£62.21
Portfolio cost	£63,060.54		+£51.25
Portfolio sell value (bid price-commission)	£59,067.29	(-6.3%)	-£1,582.60
Potential profits	£8,372.05		-£58.23
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£705.26		+£113.45
Yr 6 projected avg monthly profit	£105.09	(3.0%)	+£14.32
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,131.87		+£113.45
Average monthly cash profit	£334.27	(9.6%)	+£0.55
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Cash up slightly as I wanted a bit of a buffer when I re-invested the IQE:IQE sale. Tiny profit from IQE has raised long term performance by 55p a month. Profits are almost flat as JLP:Jubilee Metals didn't change this week and portfolio value drop is mainly OPTI:Optibiotix.

Pretty much the same as the combined chart.

Ditto

The SIPP looks like this after week 272 overall and week 12 of year 6.

			Weekly Change
Cash	£234.46		-£75.75
Portfolio cost	£63,887.47		+£266.26
Portfolio sell value (bid price - commission)	£61,446.31	(-3.8%)	-£966.45
Potential profits	£4,959.78		+£193.14
Yr 6 Dividends	£419.17		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£2,375.35		+£202.46
Yr 6 projected avg monthly profit	£991.08	(29.7%)	-£10.34
Total Dividends	£2,486.25		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£17,834.79		+£202.46
Average monthly cash profit	£313.06	(9.4%)	+£2.08
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+0%

The opposite to the ISA in that I ended up with less cash after re-investing the ITX:Itaconix sale. That had a slightly better long term improvement of £2 per month and potential profits went up thanks to the magic formula shares, which reduced the impact of the losses from OPTI:Optibiotix.

A familiar pattern

Looking forward to getting past March so that nasty low point is off the chart and I can raise the lower axis to -£20,000

The trading account looks like this after week 238 overall and week 30 of year 5

			Weekly Change
Cash	£249.58		+£0
Portfolio cost	£2,364.43		+£0
Portfolio sell value (bid price - commission)	£1,865.59	(-21.1%)	+£6.17
Potential profits	£0		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£631.65		+£0
Yr 5 projected avg monthly profit	£93.00	(47.2%)	-£3.20
Dividends	£60.10		+£0
Profit from sales	£918.02		+£0
Average monthly cash profit	£17.81	(9.0%)	-£0.07
(Sold stocks profit + Dividends - Fees  / Months)

So upsetting that I can't continue my good run of form and bank some more profits. I tiny tick up this week mainly thanks to CAML:Central Asia Metals which is only 6% down. DDDD:4D Pharma is even better at only 5% down so there's hope that I can sell something soon.

Need to get back to that nice pattern we've enjoyed for the majority of this year.

Below the trend line! Bad!

It feels great to have made a reasonably significant investment in DDDD:4D Pharma now. Although I had a bit of fun trading it and made £2,258 profit, I've learnt to my cost with SBTX:SkinBioTherapeutics that it's very stressful being out of a share you really like and are certain of great things in the long term. I should trade with my trading account and stick to long term investing with my main accounts.

I just have the big problem of how the hell I'm going to get back into SBTX as there's no way I'm paying 40p! I just have to keep reminding myself that OPTI:Optibiotix own a quarter of the company so I am invested indirectly. My biggest fear is that they are doing what OPTI did when they went above 130p only to plummet and hold in the 50p to 70p range for years. I think 40p is at the very top of the range SBTX is likely to stay in until profitable. Just got to remember it's better to be out of a share wishing you were in, than to be in a share wishing you were out.

Week 287 Review

This wasn't a bad week, with many of last week's losses recouped and a 2p rise in OPTI:Optibiotix contributing £2,600 to the rise of £4,567. That narrowed the deficit between cost and value to £4,390 and increased total portfolio value to £125,193.

Most substantial loser was my biggest mistake in a long while HUM:Hummingbird Resources. A somewhat underwhelming trading statement with worryingly high costs of gold production mean this is likely to languish until the price of gold goes back above $2,000. They dropped 16% this week to make my holding 27% down in not many weeks. Deeply upsetting for my trading account but less of a worry for my SIPP.

ITX:Itaconix was a really good buy at 3p, but doubling my holding at 6.7p was a big mistake now they've dropped to 5.5p. That was a 7% fall this week and shares that would have been up by about 60% are only up by 27% now. I like the story though so will keep these for a while - or will I?

It's all good news from here.

ITV:ITV climbed 6% which was especially satisfying as these didn't fall badly last week. They are now 55% up and I really hope will announce a dividend as a magic formula share not paying a dividend should really be thrown out for disobeying the rules.

TLOU:Tlou Energy have been slowly creeping up all week. They climbed 7% in the end and are now 52% down. My purchase of 8,809 shares at 2.2p in the open offer is looking great now they are selling at 3.5p, and will hopefully speed up the rate at which I get back into profit. These are still very high risk but the reward could be epic.

FXPO:Ferrexpo climbed 8% to take back half of last week's losses so I'm hoping for the same next week. They are 63% up so I can't complain. If only the uncertainty over the ex-CEO could be resolved I'm sure these would get away from their P/E ratio of 6 and double in value.

APAX:Apax Global Alpha didn't fall much last week, and so the 10% rise this week was unexpected. They are now 42% up, and with a 3.3% dividend so far, which will double in March, it's tempting to keep these in the SIPP for the long haul. The magic formula rule is to review after 12 months, so I will do that. It's not that I wouldn't mind keeping these, but a case of there may be something better.

TRX:Tissue Regenix climbed 10% and thanks to my massive buy of 90,594 shares at 0.54p my average price came down from almost 19p to 2.25p, so the recovery is much swifter than it would have been and my holding is only 68% down when it was 98% down a few months ago. Costs are still worryingly high, but they are producing and selling lots, so there is light at the end of the tunnel.

DDDD:4D Pharma are becoming one of my favourite shares and I want a load more. The update on the cancer trials was amazing. They are curing a wide range of cancers and I can't believe that news isn't causing a much bigger hike in share price. The 12% rise to 130.5p this week took my SIPP holding into profit by 5%, so at least some of the cash I was meant to have reserved for buying back SBTX:SkinBioTherapeutics has done some good. Tragically SBTX has taken off so my chances of getting back in at a decent rate are diminishing rapidly. I may re-target my IQE:IQE ISA holding to DDDD instead, but I don't have long before the Nasdaq listing and IQE just won't get up to the magic 100p I need to make enough profit to be able to write off the disaster that is BLCC:Block Commodities.

Share of the Week is JLP:Jubilee Metals which was the worst performer last week dropping 24%. This week it made up 19% of that drop, and my holding is back up to £8,372 (194%) potential profit. Nice! I'm hoping this means we've ridden through the choppy waters caused by the directors selling all their shares and can wait excitedly for more operational updates, especially for our copper production.

Only made up half of last week's drop, and not enough to get back in the black.

Hoping for the same again next week to get us over the line.

Here's the ISA and shares portfolio after week 27 of year 6

			Weekly Change
Cash	£29.20		-£3.75
Portfolio cost	£63,009.29		+£0
Portfolio sell value (bid price-commission)	£60,598.64	(-3.8%)	+£2,455.67
Potential profits	£8,430.28		+£764.24
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 projected avg monthly profit	£90.77	(2.6%)	-£4.11
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£333.72	(9.6%)	-£1.22
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Cash down due to monthly ISA fee, JLP:Jubilee Metals increased potential profits by £800 but IQE:IQE ate into that a little as potential profits dropped. Long term performance remains satisfactory but after 6 months the annual performance needs a boost.

Pretty much the same as the combined chart

Ditto

The SIPP looks like this after week 271 overall and week 11 of year 6.

			Weekly Change
Cash	£310.21		-£16.66
Portfolio cost	£63,621.21		+£0
Portfolio sell value (bid price - commission)	£62,146.50	(-2.3%)	+£2,132.10
Potential profits	£4,766.64		+£665.61
Yr 6 Dividends	£419.17		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£2,172.89		+£0
Yr 6 projected avg monthly profit	£1,001.43	(30%)	-£107.37
Total Dividends	£2,486.25		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£17,632.33		+£0
Average monthly cash profit	£310.98	(9.3%)	-£1.43
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+0%

Similar story to the ISA, but with 7 shares in profit and DDDD:4D Pharma becoming the 8th. Looking at whether I want to sell anything, there are a few options. Half of my CMCL:Caledonia Mining purchase was just because they had dropped so much and I'll sell on a rebound, HUM:Hummingbird Resources may have been a mistake so I'll try and offload those, and I may abandon ITX:Itaconix for a while in order to get more DDDD.

All the charts are very similar this week.

Heading back in the right direction.

The trading account looks like this after week 237 overall and week 29 of year 5

			Weekly Change
Cash	£249.58		+£0
Portfolio cost	£2,364.43		+£0
Portfolio sell value (bid price - commission)	£1,859.42	(-21.4%)	-£20.50
Potential profits	£0		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£631.65		+£0
Yr 5 projected avg monthly profit	£96.20	(48.8%)	-£3.44
Dividends	£60.10		+£0
Profit from sales	£918.02		+£0
Average monthly cash profit	£17.88	(9.1%)	-£0.08
(Sold stocks profit + Dividends - Fees  / Months)

The dip was mainly due to HUM:Hummingbird Resources. My good run in this account seems to have stalled.

A few bad weeks on the run

Disaster - we've crossed to the wrong side of the trend line! First time in 10 weeks.

My experience after selling all my SBTX:SkinBioTherapeutics shares has taught me never to completely sell out of a company I really like again. It's absolute torture being out of it completely as it does well. Even if I'd just kept a token amount I could still feel happy, instead of resentful and bitter. I'm convinced this share will be absolutely huge, and although I have an indirect holding via OPTI:Optibiotix, it doesn't feel the same as being an actual shareholder. I thought SBTX would behave the same as OPTI with wild swings for a long period, but that may not be happening. I can't bring myself to pay the current share price as I believe it's way too high, but it's not coming back down to a price where I feel I can invest. Deeply frustrating, but I only have myself to blame.

Having said that, I did make £5,217 profit selling them so maybe I can live with the frustration.

Week 286 Review - Misery as the yo-yo strikes again

I'm getting fed up of these massive swings every week. Just as I think things are finally going OK they plunge to a massive loss again. Almost all last week's gains were wiped out as my portfolio crashed by £10,176 to go back into the red with a deficit between cost and value of £8.957. The total value dropped to £120,646.

So, it's a deep breath before we hurtle into abject misery.

JLP:Jubilee Metals was the biggest loser this week, dropping 24% in a combination of profit taking and people getting jitters because they always manage to do something stupid just as things start looking good. This week it was a pitiful publicity stunt as the two main directors bought back a measly 500,000 shares after selling millions the week before. It's a real worry that they thought this was a good idea. They may as well have just waited to cash in their options.

FXPO:Ferrexpo paid out a nice special dividend of £35 taking their total divi to £101 in less than a year. That's a nice 10% on top of the 55% growth so far. Shame they dropped 16% this week else they would have been quids in for Share of the Week.

IQE:IQE had a major stutter this week and dropped 10%. It may take longer than I thought before I can sell the trading pot.

OPTI:Optibiotix fell 6p and contributed £8,000 of this week's losses. Here was me eyeing up 84p so I could sell the ones in my share account, but no chance. Back we go below 60p after knocking on resistance and failing to break through yet again.

CAML:Central Asia Metals had another bad week and are sinking like a brick. Another 5% this week, but I think it's a general mailaise as lots of shares have dropped by the same amount.

So many have dropped by 5% that I couldn't be bothered trying to explain why. They all dropped because it's been a shit week on the market. CMCL:Caledonia Mining, HUM:Hummingbird Resources, PAY:Paypoint and POLR:Polar Capital Holdings all fell by 5%.

There is no Share of the Week this week as none of them deserve it. A few managed a feeble 1% gain but everything else is flat or down. It really was a rubbish week

Pleh!

I usually witter on about being above the trend line, but can't be bothered.

Here's the ISA and shares portfolio after week 26 of year 6

			Weekly Change
Cash	£32.95		+£0
Portfolio cost	£63,009.29		+£0
Portfolio sell value (bid price-commission)	£58,142.97	(-7.7%)	-£5,576.31
Potential profits	£7,666.04		-£2,237.57
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 projected avg monthly profit	£94.88	(2.7%)	-£3.80
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£334.94	(9.6%)	-£1.18
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Great big drop and profits hammered as JLP:Jubilee Metals lost £1,000 and all OPTI:Optibiotix profits vanished.

Not as low as 2 weeks ago.

Which direction will we go next week?

The SIPP looks like this after week 270 overall and week 10 of year 6.

			Weekly Change
Cash	£326.87		+£40.94
Portfolio cost	£63,621.21		+£0
Portfolio sell value (bid price - commission)	£60,014.40	(-5.7%)	-£4,524.30
Potential profits	£4,101.03		-£819.43
Yr 6 Dividends	£419.17		+£40.94
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£2,172.89		+£0
Yr 6 projected avg monthly profit	£1,108.79	(33.2%)	-£103.48
Total Dividends	£2,486.25		+£40.94
Total Interest	£0.20		+£0
Total Profit from sales	£17,632.33		+£0
Average monthly cash profit	£312.90	(9.4%)	-£1.16
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+1%

Nice dividends from FXPO:Ferrexpo and CMCL:Caledonia Mining, and the drop in potential profits isn't quite as bad as the ISA because OPTI:Optibiotix was still loss making last week. 

This account dropped lower than it was 2 weeks ago.

Only just lower though.

The trading account looks like this after week 236 overall and week 28 of year 5

			Weekly Change
Cash	£249.58		+£0
Portfolio cost	£2,364.43		+£0
Portfolio sell value (bid price - commission)	£1,879.92	(-20.5%)	-£76.01
Potential profits	£0		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£631.65		+£0
Yr 5 projected avg monthly profit	£99.64	(50.6%)	-£3.69
Dividends	£60.10		+£0
Profit from sales	£918.02		+£0
Average monthly cash profit	£17.96	(9.1%)	-£0.08
(Sold stocks profit + Dividends - Fees  / Months)

Great big drop of £76 just as it was looking like I was getting the hang of this. No prospect of selling anything for a while now.

A bad few weeks.

Almost touching the trend line. I never expect this account to trend upwards - flat would be ideal once I'm a bit closer to break-even.

So I timed my big purchase with my £4,500 really badly and what's worse is SBTX:SkinBioTherapeutics continues to grow. It's grown so much that the market cap now exceeds OPTI:Optibiotix despite OPTI owning 25% of the company and being at least a year closer to profitability. Hopefully the problem is OPTI being too low rather than SBTX being too high, although if they do drop I'll be able to buy back in.

Week 285 Review - Boing! Back in the black

A complete reversal of last week, with OPTI:Optibiotix recovering all losses whereas my other shares didn't fare so well. The result was an increase in value of £10,958 to go back into profit by £1,218 and increase overall portfolio and cash value to £130,782.

Worst performer was ITX:Itaconix, but that's because I doubled my holding and effectively halved the percentage gain. It fell by 38% but is still 38% up as it had been 76% up which was flat with last week.  I'm fairly staggered with the number of products they are in, and even though there are some red flags in the finances, the profits that will come from being in so many products ought to sort them out.I bought 7,440 shares at 6.72p costing £508.92.

Next worst performer was FXPO:Ferrexpo which dropped 11%. That's on the back of a 5% drop last week. However, I noticed on my account that they went ex-dividend on 14th January for a special dividend which will be paid next Thursday, so some of the sell off could be those getting out after qualifying for the dividend.A bit of a bonus as I didn't spot the announcement in the last trading update. It should be worth about £36.

Unfortunately my next worst performer was CAML:Central Asia Metals, dropping 6% after a 16% fall last week. I can only assume this is traders taking profits after the recent massive rise, but unfortunately it happened just before my trading account holding was high enough to sell. I guess I can wait a few more weeks.

The final big faller this week was ITV:ITV which lost 5%. I suspect this is another case of people selling due to the recent sustained rise. They are still 49% up so I'm happy with that. Re-instatement of the dividend would be my main wish because magic formula shares are meant to earn dividends. I've already had around £250 dividends from the combined magic formula portfolio in the last six months which is 3.6% of the £7,000 and way better than I'd get in a building society.

CMCL:Caledonia Mining actually dropped this week, but I invested another £1,000 buying 87 shares at 1,137.5p costing £998.58. By doubling my holding in a loss making share I effectively halved my deficit from 23% down to only 13%. This was part of me blowing all the cash I had reserved for SBTX:SkinBioTherapeutics when their share price went crazy and it became clear they would not be back at my preferred price for some time. I'm not holding cash that long so put it into shares I think are about to rally. CMCL have a P/E ratio of 4.2 which is utterly crazy given they are paying increasing monthly dividends, the next one of which is due for payment on Friday after going ex dividend on Thursday. I missed it by a day with the new shares but got a good price.

IQE:IQE have been gradually sneaking up and climbed another 13% this week. My ISA holding is now 14% up and making £304 potential profit. This is now my SBTX:SkinBioTherapeutics pot. I'll sell at around 100p and hold the cash for when SBTX drops back to 20p.

Share of the Week is OPTI:Optibiotix which gained back all of last week's 9p drop to climb by 14% back into profit of £500. I got so excited by the bullish signals coming from chartists and from the bottleneck of news predicted to break over the next few months that I used half my SBTX:SkinBioTherapeutics cash to buy another 3,032 at 65.9454p costing £2,008.41. This is the first time in a very long time that I have slightly increased my average price, but only by a fraction as my average is around 64p.The purchase took my holding to just over 130,000 shares.

The red line went back up due to re-investing the cash and the green line is now above it - huzzah!

Granted we're only just over the zero line...

Here's the ISA and shares portfolio after week 25 of year 6

			Weekly Change
Cash	£32.95		+£0
Portfolio cost	£63,009.29		+£0
Portfolio sell value (bid price-commission)	£63,719.28	(1.1%)	+£6,759.13
Potential profits	£9,903.61		+£1,211.95
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 projected avg monthly profit	£98.68	(2.8%)	-£4.11
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£336.12	(9.7%)	-£1.18
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Fairly quiet apart from the big surge from OPTI:Optibiotix. Both sell value and potential profits are up slightly less than they fell last week, mainly thanks to a 2% drop for JLP:Jubilee Metals.

Not a record high, but back on the right side of the red line which I thought might take longer than this to achieve after the massive drop last week.

I shudder to think what will happen next week...

The SIPP looks like this after week 269 overall and week 9 of year 6.

			Weekly Change
Cash	£285.93		-£4,523.75
Portfolio cost	£63,621.21		+£4,527.75
Portfolio sell value (bid price - commission)	£64,538.70	(1.4%)	+£4,194.84
Potential profits	£4,920.46		-£705.41
Yr 6 Dividends	£378.23		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£2,172.89		+£0
Yr 6 projected avg monthly profit	£1,212.27	(36.3%)	-£151.54
Total Dividends	£2,445.31		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£17,632.33		+£0
Average monthly cash profit	£312.90	(9.4%)	-£1.16
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		+0%

Nearly all the cash was piled into shares, and the value went up by an extra £4,194 on top of that. OPTI:Optibiotix is still loss making in this account so didn't contribute enough to profits to mitigate the drop of CAML:Central Asia Metals, FXPO:Ferrexpo and ITV:ITV.

I've already mentioned the purchases in ITX:Itaconix, OPTI:Optibiotix and CMCL:Caledonia Mining. I also bought some more DDDD:4D Pharma as I think they could have a significant re-rate after the Nasdaq listing. I may top slice some of these to get back to £4K worth of SBTX:SkinBioTherapeutics if they ever drop in price again, but I really want a decent amount of DDDD to hold long term. I bought 861 shares at 116.0152p costing £1,007.84. My combined holding is down by 8% but hopefully not for long.

This account has just about managed to stay above the green line on this chart thanks to last week's big cash buffer.

This chart didn't have the benefit of cash, and is also quite revealing that we're not in anywhere near as good shape as we were 2 weeks ago.

The trading account looks like this after week 235 overall and week 27 of year 5

			Weekly Change
Cash	£249.58		+£0
Portfolio cost	£2,364.43		+£0
Portfolio sell value (bid price - commission)	£1,955.93	(-17.3%)	+£4.34
Potential profits	£0		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£631.65		+£0
Yr 5 projected avg monthly profit	£103.33	(52.4%)	-£3.98
Dividends	£60.10		+£0
Profit from sales	£918.02		+£0
Average monthly cash profit	£18.04	(9.2%)	-£0.07
(Sold stocks profit + Dividends - Fees  / Months)

Just about as flat as it can get, with a rise in IQE:IQE offset by a drop in CAML:Central Asia Metals. The non-suspended shares are down by 4%, 9%, 16% and 20% with HUM:Hummingbird Resources the one nearest to breaking into profit.

If OPTI:Optibiotix goes on a charge, then I very much look forward to doubling the amount of money in this account and having 10 holdings on the go at once. I really need to get to the point where I'm selling one a week.

If I can hold the green line at this level while the orange line continues to drop as I extract profits, then I'll be very happy indeed.

A long recovery, but definitely a recovery.

So we're back where we were 2 weeks ago and in profit. Happy days that were very short lived last time. Will we see the same happen again or will we hold in profit next week? OPTI:Optibiotix has been pushing at the door for a very long time now, as deal after deal was made. I've always believed that it would break out one day, and when it does the breakout could be spectacular, especially after being held in this trading range for so long. 

If we hadn't have got ahead of ourselves a few years ago and rocketed to 132p I think we would have been on a very gradual climb to 100p by now. That feels like the right price for where we are at the moment given the rapid rate of revenue growth and large pipeline of products being developed with global markets.

Let's hope our time has finally come to fly!